Kelly, Lois M.
Rutter, Justine C. https://orcid.org/0000-0002-0851-0887
Lin, Kevin H.
Ling, Frank
Duchmann, Matthieu
Latour, Emmanuelle
Arang, Nadia
Pasquer, Hélène
Ho Nhat, Duong
Charles, Juliette
Killarney, Shane T. https://orcid.org/0000-0002-8471-6641
Ang, Hazel X. https://orcid.org/0000-0002-4194-7204
Namor, Federica
Culeux, Cécile
Lombard, Bérangère https://orcid.org/0000-0001-9044-3662
Loew, Damarys https://orcid.org/0000-0002-9111-8842
Swaney, Danielle L. https://orcid.org/0000-0001-6119-6084
Krogan, Nevan J. https://orcid.org/0000-0003-4902-337X
Brunel, Luc
Carretero, Élodie
Verdié, Pascal
Amblard, Muriel
Fodil, Sofiane
Huynh, Tony
Sebert, Marie https://orcid.org/0000-0003-4376-4097
Adès, Lionel https://orcid.org/0000-0002-9020-8766
Raffoux, Emmanuel
Fenouille, Nina
Itzykson, Raphaël https://orcid.org/0000-0003-2139-6262
Lobry, Camille https://orcid.org/0000-0003-0550-4921
Benajiba, Lina
Forget, Antoine
Martin, Anthony R. https://orcid.org/0000-0001-6187-6979
Wood, Kris C. https://orcid.org/0000-0002-5887-2253
Puissant, Alexandre https://orcid.org/0000-0002-3997-9282
Article History
Received: 24 October 2023
Accepted: 13 May 2024
First Online: 30 May 2024
Competing interests
: The Krogan Laboratory has received research support from Vir Biotechnology, F. Hoffmann-La Roche and Rezo Therapeutics. N.J.K. has financially compensated consulting agreements with Maze Therapeutics. N.J.K. is the president and on the board of directors of Rezo Therapeutics and a shareholder in Tenaya Therapeutics, Maze Therapeutics, Rezo Therapeutics and Interline Therapeutics. K.C.W. is a cofounder, consultant and equity holder at Tavros Therapeutics and Celldom, is a consultant and equity holder at Simple Therapeutics and Decrypt Biomedicine and has performed consulting work for Guidepoint Global, Bantam Pharmaceuticals and Apple Tree Partners. The other authors declare no competing interests.